NCT01939522View on ClinicalTrials.gov

Protection Against Pneumococcal Infection in Children With T1DM

PHASE4CompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2013

Primary Completion Date

April 30, 2016

Study Completion Date

January 31, 2017

Conditions
Type 1 Diabetes Mellitus
Interventions
BIOLOGICAL

13-valent pneumococcal conjugate vaccine (PCV13)

Trial Locations (1)

OX3 9DU

Oxford University Hospitals NHS Trust, Oxford

All Listed Sponsors
lead

University of Oxford

OTHER

NCT01939522 - Protection Against Pneumococcal Infection in Children With T1DM | Biotech Hunter | Biotech Hunter